LOADING
Comparing AbbVie Inc (ABBV) and Pfizer Inc (PFE), both in the Health Care sector. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | ABBV | PFE |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $369.4B | $162.4B |
| P/E Ratio | 88.5 | 21.0 |
| Forward P/E | 14.8 | 9.7 |
| PEG Ratio | 0.51 | 13.77 |
| EPS | $2.36 | $1.36 |
| Revenue Growth (YoY) | 10.0% | -1.2% |
| Profit Margin | 6.9% | 12.4% |
| Return on Equity | 62.3% | 8.9% |
| Dividend Yield | 3.09% | 6.13% |
| Beta | 0.33 | 0.41 |
| 52-Week High | $241.12 | $28.75 |
| 52-Week Low | $159.05 | $19.50 |
| Volume | -- | -- |
AbbVie Inc is the larger company by market capitalization. Pfizer Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Pfizer Inc offers a higher dividend yield for income investors. Pfizer Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.